Penumbra Inc at Piper Sandler Healthcare Conference Transcript

Dec 03, 2025 / 01:00PM GMT
Release Date Price: MXN4775.7
Matt O;Brien
Piper Sandler - Analyst

' -

All right. Good morning, everybody. Thanks so much for joining us. My name is Matt O'Brien. I'm one of the med tech analysts here at Piper Sandler.

Picking off day two here was a phenomenal company in Penumbra. From the company, we have Adam who's the CEO; Shruthi, who is the President of the company. We're also joined by Arani, who's one of the co-founders and then Cecilia and Jason are in the audience as well. Thank you so much for coming all the way across the country to be with us.

Adam Elsesser
Penumbra Inc - Chairman of the Board, President, Chief Executive Officer

Happy to be here.

Questions & Answers

Matt O;Brien
Piper Sandler - Analyst

' -

So can we start with what happened in Q3, especially in the Embo and access business. As I was saying to you earlier, it was so good. I actually thought there was a mistake in the press release. But just talk about the strength that you saw there splitting the sales force and then

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot